Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

B 669

Known as: 2-Phenazinamine, 3-(cyclohexylimino)-3,5-dihydro-N,5-diphenyl-, B-669, B669 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Altered phospholipase A2 (PLA2) activity and its relationship to cation (K+, Ca2+) uptake and growth were investigated in… Expand
Is this relevant?
1996
1996
The effects of the riminophenazine antimicrobial agents clofazimine and B669 as well as those of lysophosphatidylcholine (LPC… Expand
Is this relevant?
1995
1995
The expression of MHC class II antigens by peripheral blood monocytes from normal individuals was investigated. Class II… Expand
Is this relevant?
1994
1994
The potential of the riminophenazine agents clofazimine and B669, at therapeutically relevant concentrations, to reverse P… Expand
Is this relevant?
1993
1993
Clofazimine, a riminophenazine antimicrobial agent, and its analogue B669 were investigated for their effects on FaDu cells, a… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 4
  • figure 2
Is this relevant?
1993
1993
The relationship between the phospholipase-stimulating and immunosuppressive properties of the riminophenazine anti-mycobacterial… Expand
Is this relevant?
1993
1993
The effects of the antimycobacterial agent clofazimine and its experimental analogue B669 on the phospholipase A2 activity of and… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The susceptibilities of a range of gram-positive and gram-negative microbial pathogens to clofazimine and its analog B669 (0.1 to… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1989
1989
Twenty-six dihydrophenazine compounds, including clofazimine, were investigated, at a fixed concentration of 1 mg/l, for their… Expand
Is this relevant?
Review
1986
Review
1986
  • G. F. Ames
  • Annual review of biochemistry
  • 1986
  • Corpus ID: 8499820
RAHAL J1. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in… Expand
Is this relevant?